Chasing molecular glue degraders: screening approaches

Domostegui, Ana, Nieto-Barrado, Luis, Perez-Lopez, Carles, Mayor-Ruiz, Cristina·2022·Chemical Society Reviews

Cited by (200)

Items 101–200 of 200

  1. Recent Advances in Targeted Protein Degradation Molecular Glues as Anticancer Drugs
    Yulin Shen, Wen Wen, L Chen, Nan Zhang, Cong Wei, Honggang Hu · 2025 · Clinical and Experimental Pharmacology and Physiology
  2. Nanoparticle-mediated targeted protein degradation (NanoTPD): Principles, rational design and mechanisms of degradation
    Yunting Zhang, Keran Wang, Yixiang Yang, Tao Gong, Zhirong Zhang, Renhe Liu, Yao Shi Fu · 2025 · Nano Today
  3. Design, synthesis and biological evaluation of novel quinazolinone derivatives as CRBN E3 ligase modulators
    Linyi Liu, Renhong Sun, Haixia Liu, Chaowei Ren, Yuedong Zhou, Xing Qiu, Ying Kong, Biao Jiang, Xiaobao Yang · 2022 · European Journal of Medicinal Chemistry
  4. Development of a nano-targeting chimera for the degradation of membrane and cytoplasmic proteins
    Peipei Jin, Zhaozheng Chen, Ju Zhang, Haowen Li, Pengfei Wei, Ziyu Wang, Qiyu Feng, Hongyang Wang, Da Han, Yanyan Miao · 2025 · Acta Biomaterialia
  5. Strengths, Weaknesses, Opportunities, and Potential Threat Analysis of Targeting Leucine-Rich Repeat Kinase 2 for Parkinson’s Disease Treatment: Status Quo and Quo Vadis
    Chenyu Dang, Zifan Feng, Tao Xu, Mi Li, Zhipeng Wang, H. L. Song, Rubing Wang · 2025 · Journal of Medicinal Chemistry
  6. Restoring adapter protein complex 4 function with small molecules: an in silico approach to spastic paraplegia 50
    Serena Francisco, Lorenzo Lamacchia, Attilio Turco, Giuseppe Ermondi, Giulia Caron, Matteo Rossi Sebastiano · 2024 · Protein Science
  7. Rewiring tumor immunity via zinc finger proteins: a new frontier in cancer immunotherapy
    Zimu Zhou, Wu Le, Jun‐Li Luo, Zhijun Li, Shangwei Zhong · 2025 · Journal of Translational Medicine
  8. Expanding the druggable proteome strategies and innovations in targeted protein degradation
    Ke Ma, Ting Liu, Wen-Bo Huan, Ke-Zheng Chen, Sheng‐Lin Qiao · 2025 · Nano Today
  9. A Novel Paradigm for Targeting Challenging Targets: Advancing Technologies and Future Directions of Molecular Glue Degraders
    Yifan Zhang, Linlin Li, Jiayi Xu, Chun-Chen Che, Jiaqing Jia, Haohao Lu, Qidong You, Xiaoli Xu · 2026 · Molecules
  10. Rational engineering of degradation tail-driven CELMoD–antibody conjugates for precision malignancy therapy
    Yu Lian Guo, Yi Song, Hanlin Wang, Lu Yang, Jingyu Zhang, Zheyuan Shen, Weijuan Kan, Yuxian Wang, Haiting Duan, Shuangshuang Geng et al. · 2025 · Acta Pharmaceutica Sinica B
  11. Chemical rewiring of ubiquitination by degraders and their selectivity routes
    Rory Whelan, Cristina Mayor‐Ruiz · 2024 · Nature Structural & Molecular Biology
  12. The antitumor peptide M1-20 induced the degradation of CDK1 through CUL4-DDB1-DCAF1-involved ubiquitination
    Huitong Bu, Chaozhu Pei, Min Ouyang, Yan Chen, Yu Li, Xiaoqin Huang, Yongjun Tan · 2024 · Cancer Gene Therapy
  13. Kinase-Bench: Comprehensive Benchmarking Tools and Guidance for Achieving Selectivity in Kinase Drug Discovery
    Tian‐Hua Wei, Shuangshuang Zhou, Xiaolong Jing, Jia‐Chuan Liu, Meng Sun, Zong-Hao Zhao, Qingqing Li, Zixuan Wang, Jin Yang, Yun Zhou et al. · 2024 · Journal of Chemical Information and Modeling
  14. Toward In Silico Design of Protein–Protein Interaction Stabilizers
    Jintao Zhu, Luhua Lai, Jianfeng Pei · 2023 · ACS Central Science
  15. Selective degradation of BRD9 by a DCAF16-recruiting targeted glue: mode of action elucidation and in vivo proof of concept
    Scott J. Hughes, Wojciech J. Stec, Colin T. R. Davies, David J. McGarry, Alicia Williams, Iván del Barco Barrantes, Rebecca Harris, Dominic D. G. Owens, Alexander Fawcett, John Hellicar et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  16. Comparative assessment of co-folding methods for molecular glue ternary structure prediction
    Yiyan Liao, Jintao Zhu, Juan Xie, Luhua Lai, Jianfeng Pei · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  17. Targeted protein degradation: therapeutic potential and challenges of PROTACs and molecular glues
    Sun Kim, Eui‐Bae Jeung · 2025 · Journal of Biomedical Translational Research
  18. USP5 deubiquitylates and stabilizes FcεRIγ to enhance IgE-induced mast cell activation and allergic inflammation
    Zi-Wen Zhou, Xue-Ting Xu, Qiu-Ni Liang, Yan-Mei Zhou, Wan-Zhen Hu, Shan Liu, Yu-Xin Jiao, S C Zhang, Kunmei Ji, Jiajie Chen · 2025 · Science Signaling
  19. Targeted protein degradation of HSP90 and associated proteins for cancer therapy via PROTACs and beyond
    Gulshan Kumar, Gouri Tyagi, Vikramdeep Monga · 2025 · RSC Medicinal Chemistry
  20. Clues for glues: from serendipity to nature’s blueprints in degrader discovery
    Zuzanna Kozicka · 2025 · Essays in Biochemistry
  21. Molecular glue degraders: Rational design, specificity engineering, and advanced delivery
    Lieen Ma, Ning Wang, Jingjing Zhu, Lingjie Wu, Shan He, Bin Zhang · 2026 · Acta Pharmaceutica Sinica B
  22. Tumor microenvironment activatable immunomodulator for cancer immunotherapy
    Weiqi Wang, Xingxing Liu, Zijiao Yan, Ke Yan, Mengjiao Zhou, Yumin Yang, Haijun Yu · 2026 · Journal of Controlled Release
  23. Advantages of PROTACs in achieving selective degradation of homologous protein families
    Luxi Yang, Xinfei Mao, Jingyi Zhang, Jing Shu, Wenhai Huang, Xiaowu Dong, Yinqiao Chen, Mingfei Wu · 2026 · Beilstein Journal of Organic Chemistry
  24. Targeted delivery of proteolysis-targeting chimeras (PROTAC) and molecular glue degraders (MGD)
    Mainak Banerjee, Alexandre Detappe, Twan Lammers · 2026 · Advanced Drug Delivery Reviews
  25. Pan-cancer proteogenomic interrogation of the ubiquitin-proteasome system
    Tania J González-Robles, Maha Khan, Paul Sastourne-Haletou, Marisa Triola, Hua Zhou, Yuki Kito, Sharon Kaisari, David Fenyö, Gergely Róna, Yadira M. Soto‐Feliciano et al. · 2026 · Cell Death and Differentiation
  26. Valorization of residual lignin from corncob residues into thermosensitive lignin-based “molecular glues” for recycling cellulase
    Jinxian Shan, Feiyun Li, Hongming Lou, Yanjun Tang · 2024 · International Journal of Biological Macromolecules
  27. Discovery and Mechanistic Elucidation of NQO1‐Bioactivatable Small Molecules That Overcome Resistance to Degraders
    Bárbara M. G. Barbosa, Aikaterini Sfyaki, Sergi Rafael, Ferran José‐Duran, Joan Pous, Carolina Sánchez, Carles Perez‐Lopez, Mar Vilanova, Marko Cigler, Marina Gay et al. · 2023 · Angewandte Chemie International Edition
  28. Native mass spectrometry for proximity-inducing compounds: a new opportunity for studying chemical-induced protein modulation
    Emanuele Fabbrizi, Francesco Fiorentino, Fabrizio Casano, Antonello Mai, Dante Rotili · 2025 · Expert Opinion on Drug Discovery
  29. PhenoDEL as a Novel Screening Strategy Based on Intracellular Protein Degradation Activity
    Yuichi Onda, Yurika Ochi, Toshihiro Araki, Miho Kageoka, Shuzo Takeda, Kazunori D. Yamada, Takehiko Ueda, K. Ohno, M. Tanaka, Daiki Sakai et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  30. Optimization and Evaluation of Complementary Degrader Discovery Assays for Application in Screening
    Johanna Huchting, Arjen Weller, Moyra Schweizer, Mona Brandt, Jan Heering, Maria Kuzikov, Markus Wolf, Jeanette Reinshagen, Markus A. Queisser, Philip M. Gribbon et al. · 2025 · ACS Pharmacology & Translational Science
  31. Mapping the global landscape of molecular glues in drug discovery: a bibliometric analysis from 2010 to 2024
    Sonali Labhade, Ritesh P. Bhole, Pawan N. Karwa, Harshad S. Kapare, Subhashini Singh · 2025 · Naunyn-Schmiedeberg s Archives of Pharmacology
  32. Molecular glues and PROTACs: unlocking targeted protein degradation in plant biology
    Carla Donderis-Fagoaga, Lidia Orea-Ordóñez, Jorge Lozano‐Juste · 2026 · Journal of Experimental Botany
  33. Discovery and Mechanistic Elucidation of NQO1‐Bioactivatable Small Molecules That Overcome Resistance to Degraders
    Bárbara M. G. Barbosa, Aikaterini Sfyaki, Sergi Rafael, Ferran José‐Duran, Joan Pous, Carolina Sánchez, Carles Perez‐Lopez, Mar Vilanova, Marko Cigler, Marina Gay et al. · 2023 · Angewandte Chemie
  34. Research advancements in molecular glues derived from natural product scaffolds: Chemistry, targets, and molecular mechanisms
    Lina Yin, Tingting Niu, Ling Li, Wei Dong Yu, Bo Han, Asma Rehman, Ke‐Wu Zeng · 2025 · Chinese Herbal Medicines
  35. An in-silico approach for novel molecular glue design by rationalizing known molecular glue mediated ternary complex formation
    Ben Geoffrey A S, Nagaraj M. Kulkarni, Deepak Agrawal, Nivedita Bharti, Rajappan Vetrivel, Kishan Gurram · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  36. ZNF276 and WIZ are CRBN neosubstrates involved in the anti-angiogenic activity of thalidomide and immunomodulatory drugs
    Takumi Ito, Tomoko Asatsuma‐Okumura, Akinori Endo, Junichi Yamamoto, Yoshiko Iwai, Yuki Yamaguchi, Mikihiko Naito, Hiroshi Handa, Yasushi Saeki · 2023 · Research Square
  37. Molecular Degraders: A Comprehensive Review of Small Molecule Induced Protein Degradation Strategies
    Deepanshu Sindhwani, Kaushal Arora, Pankaj kumar, Prabhakar Kumar Verma, Vivek Vidyadhar Bhosale · 2025 · Current Protein and Peptide Science
  38. Chemical and genetic molecular glues to degrade CoREST corepressors
    Yingqi Song, Qingjun Li, Chunquan Sheng · 2025 · Acta Pharmaceutica Sinica B
  39. Degraders of cell cycle- and antiapoptosis-related proteins
    Yingqiong Zhang, Rong Dong, Bo Zhang · 2025 · Elsevier eBooks
  40. Discovery of fluorescent theranostic molecular glues for real-time visualization and target degradation toward eEF2K
    Tingting Liu, Jie Ma, Gaopan Dong, Mei Zhang, Subin Song, Xuerui Zhang, Shixiang Qi, Mingyu Cheng, Wenjie Liu, Xu Wang et al. · 2025 · European Journal of Medicinal Chemistry
  41. Microproteins: novel multi-functional regulators in health and disease
    Jia‐Peng He, Haozhe Zhang, Bin Liao, Qianyu Xu, Jeremy Yuen‐Chun Teoh, Chi‐Fai Ng, Dinglan Wu, Xian-Tao Zeng, Chris Soon Heng Tan, Hailiang Hu · 2025 · Oral Science and Homeostatic Medicine
  42. A DRUG HUNTER’S APPROACH TO MOLECULAR GLUES
    Daniel S. La, Christopher G. Nasveschuk, Adam M. Gilbert · 2025 · Medicinal chemistry reviews
  43. Computational approaches enhance the design of molecular glue degraders for undruggable proteins
    Sirishantha G M A Deshani, Gunarathna R D S Madushani, Veranja Karunaratne, Kumar Vinit, Ge‐Fei Hao · 2025 · Drug Discovery Today
  44. An Integrated Approach Combining Surface Plasmon Resonance Screening with Proteomics Enables Discovery of Natural Molecular Glue Degraders
    Yueying Yang, Rui Zhu, Jing Liang, Hongwei Yan, Huadong Zhang, Jundan Tian, Rui Zhang, Xiaofen Liu, Ying Liu, Hua Li et al. · 2026 · JACS Au
  45. Therapeutic targeting of CDK12: a medicinal chemistry perspective
    Feifei Wang, Hongxue Dai, Kuanxin Wan, Mingliang Wang · 2026 · Bioorganic & Medicinal Chemistry
  46. Synthetic and Medicinal Chemistry Perspectives on Cereblon‐Binding Molecular Glue Degraders: Recent Advances and Emerging Trends
    Hyuck-Jae Won, Seung Mok Baek, Min Hoo Lee, Jae Hyeon Park, Jeong‐Won Shin, Yo‐Sep Yang, Yoon Hu Jang, Kyung‐Soo Inn, Nam‐Jung Kim · 2026 · European Journal of Organic Chemistry
  47. Covalent Inhibitors of Monoacylglycerol Lipase Induce Conformational Changes and Proteasomal Degradation
    Jordan A. Pham, Thanawat Thaingtamtanha, William McLeish, David Lefebvre, Spencer M. Uguccioni, Roxana Filip, Francesco Gentile, John Paul Pezacki · 2026 · Journal of the American Chemical Society
  48. A Scalable, Direct‐to‐Biology Platform for Accelerated Discovery of Cereblon‐Based Molecular Glue Degraders
    Jia‐Yu Wang, Guang‐Liang Yin, Yijia Chi, Yuan‐Peng Feng, Chu‐Cheng Zhou, Hui‐Jun Nie, Zhi‐Gao Zhang, Shuting Meng, Yang Chen, Zhi‐Peng Zhou et al. · 2026 · Angewandte Chemie International Edition
  49. Selective CDK2 Degradation via Noncanonical Recruitment
    Yuanyuan Pei, Weiye Lin, Xinzhu Li, Yuhang Meng, Yuling Yin, Benxun Pan, Lixin Zhou, Linhui Cao, Yong Cang, Yi Jiang et al. · 2026 · Journal of Medicinal Chemistry
  50. UbiDash: A UPS proteomic atlas for tissue-aware degrader design
    Tania J González-Robles, Paul Sastourne-Haletou, Marisa Triola, Maha Khan, Áron Bartha, Jeffrey Estrada, Yadira M. Soto‐Feliciano, Benjamin G. Neel, David Fenyö, Michele Pagano et al. · 2026 · Cell Death and Differentiation
  51. The synthetic landscape of cereblon (CRBN) binders: from thalidomide to emerging chemotypes
    Sergi Rafael, Carolina Sánchez, Rory Whelan, Clifford Harris, Xavier Verdaguer, Cristina Mayor‐Ruiz, Antoni Riéra · 2026 · Chemical Society Reviews
  52. From nature to synthetic analogues: recent advances in the design and synthesis of natural product-based libraries
    Iván Cheng‐Sánchez, Irama Fuentes-Pino, Mohamed El Hllafi, Federico Moya‐Utrera, Juan Manuel López‐Romero, Amelia Díaz, Antonio Sánchez‐Ruiz, Michio Kurosu, Francisco Sarabia · 2026 · Organic Chemistry Frontiers
  53. Artificial intelligence empowers targeted protein degradation: Core technological innovations, multi‐scenario applications, and translational prospects
    Shuanglin Qin, Rui Peng, Guangshuai Zhang, Si Yan, Jin Xiao, Zishu Liu, Ziyu Tan, Qingqing Xie, Shangjie Li, Wei Luo et al. · 2026 · Smart Molecules
  54. Berberine, a natural molecular glue degrader, overcomes CML resistance via TRIM28-mediated HIF1α ubiquitination and subsequent ferroptosis
    Rui Su, Rongjun Xu, Wenjing Shi, Wenjing Song, Xingri Zhan, Yiling Long, Xiuyuan Wang, Hong Nie, Jia Fei · 2026 · Cell Reports
  55. Ubiquitin receptor–mediated, ubiquitin-independent targeted protein degradation via 26 S proteasomes
    Seh Hoon Park, Yejin Jang, Soo-Yeon Lee, Eunseo Kim, Dawon Jeong, Insuk Byun, Jiseong Kim, Jisoo Yang, Chang‐Han Lee, Dohyun Han et al. · 2026 · Science Advances
  56. Molecular glue degraders enhance CAPRIN1-dependent lysosomal degradation of APP in Alzheimer’s disease
    Sung Han Jung, Raktim N. Roy, Xu Wang, Bin Liu, Nancy Jaiswal, Ratan K. Rai, Yuichiro Takagi, Cen Gao, Li‐Fan Zeng, Ho-Yin Lo et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  57. Targeted KRAS G12V degradation elicits efficient and durable lung adenocarcinoma regression in vivo
    Alberto J. M. Martín, Inés M. García-Pérez, Sonia San José, Pep Rojo, Carlos Riego‐Mejías, Cristina Teodósio, Bárbara M. G. Barbosa, Carolina Sánchez, Ignasi Folch-I-Casanovas, Antonia Odena Caballol et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  58. P53 upregulation by USP7-engaging molecular glues
    Boxun Lu, Zhaoyang Li, Ziying Wang, Ping An, Hang Zhang, Chao Zhong, Rui Liu, Z. Ma, Junmei Lü, Chengfang Pan et al. · 2023 · Research Square
  59. Research progress in small-molecule modulators of protein-protein interactions
    Bin Yang, Xiangbing Qi · 2023 · Chinese Science Bulletin (Chinese Version)
  60. Unveiling Innovative anti-influenza Agents Through Modern Medicinal Chemistry Approaches (2019–2023 updates)
    Chuanfeng Liu, Lide Hu, Huinan Jia, Jiwei Zhang, Guanyu Dong, Edeildo Ferreira da Silva‐Júnior, Xinyong Liu, Peng Zhan · 2023 · Future Medicinal Chemistry
  61. Pre‐mRNA Splicing Modulation
    Scott J. Barraza, Matthew G. Woll · 2024 · Methods and principles in medicinal chemistry
  62. Palbociclib, ribociclib, and abemaciclib: potent and selective CDK4/6 inhibitors for the treatment of breast cancer
    Kai Yuan, Weijiao Chen, Xiao Wang, Peng Yang · 2024 · Elsevier eBooks
  63. A Comprehensive Overview of Protacs Targeting Hsp90 and Their Client Proteins for Cancer Therapy
    Gulshan Kumar, Gouri Tyagi, Vikramdeep Monga · 2025 · SSRN Electronic Journal
  64. Targeted Protein Degradation of Metalloenzymes
    Conor O’Herin, Seth M. Cohen · 2025 · Wiley eBooks
  65. Molecular Glues as Activators for PPI
    Xiangbing Qi · 2025 · Wiley eBooks
  66. Nucleic acid-encoded antibody gene transfer-next generation of antibody therapies
    Kaikai Yu, Geng Xiao, Baichuan Chen, Na Xu, Wensen Liu · 2025 · Drug Delivery
  67. Progress on molecular glue degraders
    Jiaqi Chen, Zhiheng Deng, Haoxiang Li, Lei Liu · 2025 · Scientia Sinica Chimica
  68. Degradation of Cyclin-Dependent Kinase: A New Weapon for Cancer Therapy
    Xing Tian, Xiaojie Dai, Ye Zhong, Maosheng Cheng, Yang Liu · 2025 · Pharmaceutical Fronts
  69. A CK2-FBXW11 kinase-E3 ubiquitin ligase cascade is a metabolic sensor regulating Tryptophan 2,3-dioxygenase stability
    Alina S. Thielen, Bastian Bräuning, Karthik V Gottemukkala, Judith Müller, Jesuraj Rajan Prabu, Simon Klaessens, Benoit J. Van den Eynde, Peter J. Murray, Brenda Arlene Schulman · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  70. Molecular Glue Degraders Redefining Targeted Therapies From Discovery to Therapeutic Applications
    Jiaye Wen, Jingtian Yu, Wuqiang Wen, Baishan Jiang · 2026 · MedComm – Oncology
  71. Indazolone-Based Molecular Glue Degraders as a Tunable Platform for Reprogramming Cereblon Substrate Specificity
    Hui‐Jun Nie, Jiamin Wang, Hao Xu, Yin-Jue Zhou, Guang‐Liang Yin, Xiaomim Xu, Gaoya Xu, Beijing Chen, Xian Li, Xiaobei Hu et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  72. Molecular Glues for Undruggable Targets: Mechanisms, Clinical Applications, and AI-driven Design
    Zike Chen, W. C. S. Meng, Mengyan Chen, Chen Wang, Min Shi · 2026 · Current Drug Targets
  73. A Live-Cell Analytical Platform by Using Strigolactones-Induced Dimerization System
    Kun Zang, Xinwei Lu, Chaoliang Diao, Chaoqing Dong, Jicun Ren · 2026 · Analytical Chemistry
  74. The degradation revolution: harnessing targeted protein degradation for the treatment of human diseases
    Jie Tong, Peng Wang, Saiya Ma, Jing Li, Yufei Zhan, Mengxuan Liu, Feng Jin, Guosheng Qu, Chunfu Zheng, Xiaochun Wang et al. · 2026 · Cellular and Molecular Life Sciences
  75. Harnessing Targeted Protein Degradation for Developing Brain Cancer Therapy
    Osaid Muhammad, Sophie White, Carina Jungha Dumo, Thomas I‐H. Park, Peter J. Choi, Jiney Jose · 2026 · Bioconjugate Chemistry
  76. Molecular Glue cc‐885 Inhibits VHL‐Deficient Clear Cell Renal Cell Carcinoma via ETS1 Degradation
    Taowei Yang, Qihao Li, Kun Ye, Kezhi Liu, Mi Zhou, Minyu Chen, Lican Liao, 黄康柏, Zhu Wang, Qiong Deng et al. · 2026 · Advanced Science
  77. Targeted protein degradation in the digital era: Computational challenges and opportunities for PROTACs
    Aishani Tewari, Aiswarya B. Pawar, Sudip Roy · 2026 · In Silico Research in Biomedicine
  78. A Scalable, Direct‐to‐Biology Platform for Accelerated Discovery of Cereblon‐Based Molecular Glue Degraders
    Jia‐Yu Wang, Guang‐Liang Yin, Yijia Chi, Yuan‐Peng Feng, Chu‐Cheng Zhou, Hui‐Jun Nie, Zhi‐Gao Zhang, Shuting Meng, Yang Chen, Zhi‐Peng Zhou et al. · 2026 · Angewandte Chemie
  79. The Novel Compound SIC-19 Triggers CUL4B-Mediated Ubiquitination and Degradation of SIK2
    Yeqiu Zou, Jiaqi Liu, Shunpeng Zhu, Qi Li, Qi Li, Fang Wang, Youguo Chen, J Zhou · 2026 · Molecular and Cellular Biology
  80. Discovery of CRBN ‐based molecular glue degraders targeting WIZ transcription factor
    Taejun Kim, Seongu Seong, Jung‐Ae Kim, Taeyeon Kwon, Hyun Jin Kim, Jae‐Joong Kim, Jong Yeon Hwang, Jin Hwa Cho, Kyoungmin Choi · 2026 · Bulletin of the Korean Chemical Society
  81. Design, Synthesis, and Biological Evaluation of a MyD88-Targeted Molecular Glue d21 for the Treatment of Acute Lung Injury
    Luxiao Zhu, Dan Tang, Ting Chen, Chenhui Sun, Ke Dong, Q W Chen, 戴勤学, 莫云长, Pan Chen, Jinfeng Sun et al. · 2026 · Journal of Medicinal Chemistry
  82. Small-molecule-mediated RNA targeting: emerging strategies and therapeutic potential of RiboTAC
    Wei Zhou, 金锦梅, Ye Wu, 陈红专, Weidong Zhang, Xin Luan · 2026 · Targetome
  83. Mapping Scientific Landscapes and Therapeutic Innovations of Targeted Protein Degradation: A Scientometric Review
    Chong Li, Xiangxiu Wang, He A, Tianjie Bao, Weihua Zhuang, Chengqi He, Yonghong Yang · 2026 · Pharmaceutics
  84. Nanotechnology‐Enabled Targeted Protein Degradation: Strategies, Opportunities, and Challenges
    Haoran Zhu, Yijun Zhang, Yuhua Ning, Chaoyong James Yang, Guihua Zhang, Zhi Zhu · 2026 · Small Methods
  85. PhenoDEL: A Novel Screening Strategy Based on Intracellular Protein Degradation Activity
    Yuichi Onda, Yukio Ochi, Toshihiro Araki, Miho Kageoka, Shuzo Takeda, Kazunori Yamada, Takehiko Ueda, Ken Ohno, M. Tanaka, Daiki Sakai et al. · 2026 · ACS Chemical Biology
  86. Supramolecular Degraders: An Emerging Paradigm in Targeted Protein Degradation
    Kongjun Liu, Xue Yuan, Yan Zhou, Rui Yuan, Shaocheng Xie, Yong Xia Chen, Peiyi Wang, Jian-Mei Gao, Qihai Gong · 2026 · Advanced Science
  87. Peptide-Based Molecular Glues for Targeted Protein Degradation
    Walaa S. Aburayan, Ibrahim A. Alradwan, Beshair Alsaffar, Othman A. Alhazzaa, Fahad A. Almughem, Abdullah Awad Alshehri, Ibtihal S. Alduhaymi, Mohannad Fallatah, Meshael Alturki, Hassa A. Alshaya et al. · 2026 · Pharmaceutics
  88. A Versatile DNA‐Encoded Library Platform for the Discovery of Highly Cooperative Chemical Inducers of Proximity
    Bingqi Tong, Sunny A. Tang, Yifan Deng, Zhihan Nan, Alison X. Gao, Gregory A. Michaud, Simone Bonazzi, Frédéric Berst, Frédéric J. Zécri, Shuang Liu et al. · 2026 · Advanced Science
  89. Iterative Optimization of Photoactivatable BRD4 Degraders for Aging‐Amplified Immunotherapy in Patient‐Derived Lung Cancer Organoids
    Jinrong Yang, Fa Wang, Shufei Li, Kai Xiong, Taihong Liu, Yu Chen, Hui Chao · 2026 · Angewandte Chemie
  90. Iterative Optimization of Photoactivatable BRD4 Degraders for Aging‐Amplified Immunotherapy in Patient‐Derived Lung Cancer Organoids
    Jinrong Yang, Fa Wang, Shufei Li, Kai Xiong, Taihong Liu, Yu Chen, Hui Chao · 2026 · Angewandte Chemie International Edition
  91. Recent Advances in Nanotechnology for Targeted Protein Degradation
    Mengchen Xu, Yi Yang, Jiajing Chen, Xi Wang, Shuyu Wang, Feihe Ma, Linqi Shi · 2026 · ACS Applied Materials & Interfaces
  92. A CK2-β-TrCP kinase-E3 ubiquitin ligase cascade is a metabolic sensor regulating tryptophan 2,3-dioxygenase stability
    Alina S. Thielen, Bastian Bräuning, Karthik V Gottemukkala, Judith Müller, Jesuraj Rajan Prabu, Pooja Verma, Simon Klaessens, Benoı̂t J. Van den Eynde, Gary Kleiger, Peter J. Murray et al. · 2026 · Molecular Cell
  93. The ternary complex structure as a foundation for structure-guided molecular glue design
    Angus D. Cowan · 2026 · Essays in Biochemistry
  94. From Ubiquitination to Proteasome-Directed Recruiting: Emerging Mechanisms and Therapeutic Potential in Targeted Protein Degradation
    Yaoli Shi, Jiayi Ma, Yutong Tu, Qingyi Wang, Mingzhi Wang, Jiaan Shao, Guifeng Wang, Jia Li, Huajian Zhu, Yubo Zhou et al. · 2026 · Journal of Medicinal Chemistry
  95. BindingDB Entry 50021951: Targeting cyclin-dependent kinases: From pocket specificity to drug selectivity.
    BindingDB · 2025 · UC San Diego
  96. BindingDB Entry 50020994: Facilitating the development of molecular glues: Opportunities from serendipity and rational design.
    BindingDB · 2025 · UC San Diego
  97. BindingDB Entry 50023421: TBA
    BindingDB · 2026 · UC San Diego
  98. BindingDB Entry 50023632: Small-Molecule Modulators Targeting Coactivator-Associated Arginine Methyltransferase 1 (CARM1) as Therapeutic Agents for Cancer Treatment: Current Medicinal Chemistry Insights and Emerging Opportunities.
    BindingDB · 2026 · UC San Diego
  99. BindingDB Entry 50021128: Small molecules targeting selected histone methyltransferases (HMTs) for cancer treatment: Current progress and novel strategies.
    BindingDB · 2025 · UC San Diego
  100. BindingDB Entry 50021378: Electrophile Determines Cellular Phenotypes among XPO1-Targeting Small Molecules.
    BindingDB · 2025 · UC San Diego